Literature DB >> 27023179

Swept-Source Optical Coherence Tomography Angiography of Paediatric Macular Diseases.

Paulo E Stanga, Alessandro Papayannis, Emmanouil Tsamis, Katarzyna Chwiejczak, Francesco Stringa, Assad Jalil, Tim Cole, Susmito Biswas.   

Abstract

PURPOSE: To describe the optical coherence tomography (OCT) angiography (OCTA) features of paediatric macular pathologies.
METHODS: Retrospective serial case reports of patients who underwent routine clinical examination and OCTA of the posterior pole using both a DRI OCT Atlantis prototype and Triton Swept-Source OCT. When considered necessary, imaging was performed using Optos wide-field imaging or another non-invasive imaging system. The findings were compared with the current literature.
RESULTS: Three cases with X-linked retinoschisis, 2 with epiretinal membrane, 1 with Best disease and 2 with Coats disease are fully illustrated.
CONCLUSION: OCTA is an effective, non-invasive imaging technique that can offer additional information regarding the morphologies and vascular characteristics of macular lesions in paediatric ophthalmology. Because of the rarity and characteristics of many paediatric macular pathologies, further multi-centric research is required with regard to the utilisation and features of OCTA imaging.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27023179     DOI: 10.1159/000442809

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  8 in total

1.  Swept-source and optical coherence tomography angiography in patients with X-linked retinoschisis.

Authors:  N Padrón-Pérez; J Català-Mora; J Díaz; L Arias; J Prat; J M Caminal
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

2.  Segmented swept source optical coherence tomography angiography assessment of the perifoveal vasculature in patients with X-linked juvenile retinoschisis: a serial case report.

Authors:  Francesco Stringa; Emmanouli Tsamis; Alessandro Papayannis; Katarzyna Chwiejczak; Assad Jalil; Susmito Biswas; Hassan Ahmad; Paulo Eduardo Stanga
Journal:  Int Med Case Rep J       Date:  2017-10-11

3.  Optical Coherence Tomography and Optical Coherence Tomography Angiography in Monitoring Coats' Disease.

Authors:  Wojciech Hautz; Joanna Gołębiewska; Beata Kocyła-Karczmarewicz
Journal:  J Ophthalmol       Date:  2017-03-09       Impact factor: 1.909

4.  SUBCLINICAL MACULAR CHANGES AND DISEASE LATERALITY IN PEDIATRIC COATS DISEASE DETERMINED BY QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Authors:  Roy Schwartz; Sobha Sivaprasad; Rebecca Macphee; Patricia Ibanez; Pearse A Keane; Michel Michaelides; Sui Chien Wong
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

5.  Optical Coherence Tomography Angiography Findings After Intravitreal Ranibizumab in Patients With Coats Disease.

Authors:  Gilda Cennamo; Daniela Montorio; Chiara Comune; Maria Paola Laezza; Matteo Fallico; Maria Elena Lionetti; Michele Reibaldi
Journal:  Front Med (Lausanne)       Date:  2021-01-21

6.  Multimodal imaging of foveoschisis and macular pseudohole associated with gyrate atrophy: a family report.

Authors:  Imène Zhioua Braham; Imen Ammous; Rim Maalej; Majdi Boukari; Ilhem Mili Boussen; Khalil Errais; Raja Zhioua
Journal:  BMC Ophthalmol       Date:  2018-04-12       Impact factor: 2.209

7.  Optical coherence tomography angiography vessel density in children with type 1 diabetes.

Authors:  Joanna Gołębiewska; Andrzej Olechowski; Marta Wysocka-Mincewicz; Dominik Odrobina; Marta Baszyńska-Wilk; Artur Groszek; Mieczysław Szalecki; Wojciech Hautz
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

8.  Swept source optical coherence tomography and optical coherence tomography angiography in pediatric enhanced S-cone syndrome: a case report.

Authors:  Angelo Maria Minnella; Valeria Pagliei; Maria Cristina Savastano; Matteo Federici; Matteo Bertelli; Paolo Enrico Maltese; Giorgio Placidi; Giovanni Corbo; Benedetto Falsini; Aldo Caporossi
Journal:  J Med Case Rep       Date:  2018-10-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.